학술논문
First-time adverse drug reactions, survival analysis, and the share of adverse drug reactions in treatment discontinuation in real-world rheumatoid arthritis patients: a comparison of first-time treatment with adalimumab and etanercept
Document Type
Article
Author
Source
In: Expert Opinion on Drug Safety . (Expert Opinion on Drug Safety, 2023, 22(6):485-492)
Subject
Language
English
ISSN
1744764X
14740338
14740338